Skip to main content
. 2026 Jul 13;17:1890018. doi: 10.3389/fendo.2026.1890018

Table 3.

Prevalence and odds ratio of DSPN across serum 25(OH)D quartiles.

25(OH)D, ng/mL n Prevalence, % OR (95% CI) P
Q1 (8.71–22.10) 142 96 1.00 (reference) /
Q2 (22.10–25.80) 141 95 0.85 (0.28–2.58) 0.767
Q3 (25.80–29.70) 143 75 0.13 (0.05–0.32) <0.001
Q4 (29.70–56.60) 143 31 0.02 (0.01–0.05) <0.001
P trend for ORs <0.001

25(OH)D, 25-hydroxyvitamin D; DSPN, distal symmetric polyneuropathy; OR, odds ratio; CI, confidence interval.